Edition:
United Kingdom

People: Gimv Investeringsmaatschappij Voor Vlanderen NV (GIMV.BR)

GIMV.BR on Brussels Stock Exchange

53.60EUR
10:54am BST
Change (% chg)

€0.20 (+0.37%)
Prev Close
€53.40
Open
€53.20
Day's High
€53.60
Day's Low
€53.20
Volume
6,108
Avg. Vol
13,801
52-wk High
€56.50
52-wk Low
€45.50

Diels, Bart 

Mr. Bart Diels is Head Health & Care of Gimv NV. He is Member of the Company's Management Committee. During his almost 25 years at Gimv, Bart Diels has built a successful and broad full-cycle track record, both in early- and late-stage investments, in business building, buy & build strategies and exit (IPO & trade sale) and this in different sectors. Bart has guided early stage companies such as BAI, Coreoptics, eXimius, Filepool and Metris from smart idea to successful exit. He also achieved substantial capital gains on late stage investments such as Almaviva FICS and LMS. Today, Bart is chairman of OTN Systems, Benedenti and Arseus Medical and board member of Eurocept, Spineart and Stiplastics. His broad experience is vital in further expanding the Health & Care platform, which he has headed since late 2012. He holds a Master's degree in Financial & Quantitative Economics and a Masters of Business Administration, both from the Universiteit Antwerpen (Belgium).

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --